APA (7th ed.) Citation

Zheng Y, Yu T, Mackey RH, Gayle JA, Wassel CL, Phatak H, & Kim R. (2021). Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zheng Y, Yu T, Mackey RH, Gayle JA, Wassel CL, Phatak H, and Kim R. Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors Vs Chemotherapy. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Zheng Y, et al. Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors Vs Chemotherapy. Dove Medical Press, 2021.